| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Mavacamten |
瑪伐凱泰 |
1642288-47-8 |
詳細(xì)
|
| BC-DXI-843 |
化合物BC-DXI-843 |
2421117-98-6 |
詳細(xì)
|
| Propargylcholine |
N-(2-羥乙基)-N,N-二甲基-2-丙炔-1-溴化銨 |
111755-76-1 |
詳細(xì)
|
| T-26c |
T-26c |
869296-13-9 |
詳細(xì)
|
| USP25/28 inhibitor AZ1 |
化合物AZ1 |
2165322-94-9 |
詳細(xì)
|
| FT113 |
FT113 |
1630808-89-7 |
詳細(xì)
|
| Dazoxiben |
UK-37248 |
74226-22-5 |
詳細(xì)
|
| AZD5153 |
AZD5153結(jié)晶體(API形式) |
1869912-40-2 |
詳細(xì)
|
| LIT-001 |
化合物L(fēng)IT-001 |
2245072-21-1 |
詳細(xì)
|
| GNE-617 |
N-[[4-[(3,5-二氟苯基)磺?；鵠苯基]甲基]咪唑并[1,2-A]吡啶-6-甲酰胺 |
1362154-70-8 |
詳細(xì)
|
| SR8278 |
SR8278;SR-8278;SR 8278 |
1254944-66-5 |
詳細(xì)
|
| SC-43 |
SC-43 |
1400989-25-4 |
詳細(xì)
|
| ML355 |
ML355 |
1532593-30-8 |
詳細(xì)
|
| AMG-009 |
1027847-67-1 |
1027847-67-1 |
詳細(xì)
|
| KKL-35 |
865285-29-6 |
865285-29-6 |
詳細(xì)
|
| NAcM-OPT |
化合物NACM-OPT |
2089293-61-6 |
詳細(xì)
|
| MAC-545496 |
MAC-545496 |
838810-96-1 |
詳細(xì)
|
| ETC-159 |
1,2,3,6-四氫-1,3-二甲基-2,6-二氧代-N-(6-苯基-3-噠嗪基)-7H-嘌呤-7-乙酰胺 |
1638250-96-0 |
詳細(xì)
|
| Mebeverine hydrochloride |
鹽酸麥皮凡林 |
2753-45-9 |
詳細(xì)
|
| T-26c |
HIF-1 INHIBITOR-1 |
2380261-53-8 |
詳細(xì)
|
| RET V804M-IN-1 |
化合物RET V804M-IN-1 |
2414909-94-5 |
詳細(xì)
|
| ASP7663 |
ASP 7663;ASP-7663;ASP7663 |
1190217-35-6 |
詳細(xì)
|
| SLV-2436 |
2095704-43-9 |
2095704-43-9 |
詳細(xì)
|
| 4,4,5,5-Tetramethyl-2-(3-methylbenzo[b]thiophen-2-yl)-1,3,2-dioxaborolane |
4,4,5,5-四甲基-2-(3-甲基苯并[B]噻吩-2-基)-1,3,2-二氧硼烷 |
1072811-91-6 |
詳細(xì)
|
| SR-717 |
SR-717 |
2375421-09-1 |
詳細(xì)
|
| ML327 |
1883510-31-3 |
1883510-31-3 |
詳細(xì)
|
| ATP synthase inhibitor 1 |
ATP SYNTHASE INHIBITOR 1 |
1023043-30-2 |
詳細(xì)
|
| WWL70 |
947669-91-2 |
947669-91-2 |
詳細(xì)
|
| 7-DICHLORO-2-DIMETHYLAMINOMETHYL-QUINOLIN-8-OL |
化合物PBT-1033 |
747408-78-2 |
詳細(xì)
|
| CDPPB |
3-氰基-N-(1,3-二苯基吡唑-5-基)苯甲酰胺 |
781652-57-1 |
詳細(xì)
|
| UNC926 |
UNC-926 |
1184136-10-4 |
詳細(xì)
|
| BZAD-01 |
BZAD01 |
305339-41-7 |
詳細(xì)
|
| TCN 201 |
TCN-201 |
852918-02-6 |
詳細(xì)
|
| SR9009 |
SR9009 |
1379686-30-2 |
詳細(xì)
|
| SGC707 |
N-6-異喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1687736-54-4 |
詳細(xì)
|
| RU-302 |
RU-302 是一種非選擇性的TAM 抑制劑，阻斷 TAM Ig1 胞外域和 Gas6 Lg 結(jié)構(gòu)域之間的界面。RU-302 用低微摩爾 IC50 有效阻斷 Gas6 誘導(dǎo)的 Axl 受體活化，并有效抑制肺癌腫瘤的生長(zhǎng)。 |
1182129-77-6 |
詳細(xì)
|
| SBI-0206965 |
SBI0206965; SBI-0206965; SBI 0206965. |
1884220-36-3 |
詳細(xì)
|
| ONC206 |
ONC206 |
1638178-87-6 |
詳細(xì)
|
| 1-Piperazinecarboxylic acid, 4-[3-amino-6-(2-hydroxyphenyl)-4-pyridazinyl]-, 1,1-dimethylethyl ester |
化合物SGC-SMARCA-BRDVIII |
1997319-84-2 |
詳細(xì)
|
| 4-[(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)CARBOXAMIDO]BENZOIC ACID |
4-[(5,6,7,8-四氫-5,5,8,8-四甲基-2-萘基)甲酰氨基]苯甲酸 |
102121-60-8 |
詳細(xì)
|
| Octanoic acid, 8-[(2-hydroxyethyl)[6-oxo-6-(undecyloxy)hexyl]amino]-, 1-octylnonyl ester |
SM-102 |
2089251-47-6 |
詳細(xì)
|
| 1H-Pyrazole-1-acetamide, N-methyl-N-[2-(4-methylphenoxy)ethyl]-4-[(1-oxo-3-phenoxypropyl)amino]- |
1H-Pyrazole-1-acetamide, N-methyl-N-[2-(4-methylphenoxy)ethyl]-4-[(1-oxo-3-phenoxypropyl)amino]- |
1185329-96-7 |
詳細(xì)
|
| 4-Ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine |
化合物HLY78 |
854847-61-3 |
詳細(xì)
|
| CNQX |
6-氰基-7-硝基喹喔啉-2,3-二酮 |
115066-14-3 |
詳細(xì)
|
| Benzeneacetamide, 2-[2-[2-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]ethyl]- |
AMP-945 |
1393653-34-3 |
詳細(xì)
|
| 9H-INDENO[1,2-B]PYRAZINE-2,3-DICARBONITRILE, 9-[(PHENYLMETHOXY)IMINO]- |
9-[(苯甲氧基)肟]-9H-茚并[1,2-B]吡嗪-2,3-二甲腈 |
924296-18-4 |
詳細(xì)
|
| 2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- |
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- |
2227368-54-7 |
詳細(xì)
|
| 2-Pyrazinemethanol, 6-[(2-amino-3-chloro-4-pyridinyl)thio]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]dec-8-yl]-5-methyl- |
RMC-4630 |
2172652-48-9 |
詳細(xì)
|
| DXd |
DX-8951衍生物 |
1599440-33-1 |
詳細(xì)
|
| 2-[1-(6-chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonylindol-3-yl]ethanamine;hydrochloride 1H-Indole-3-ethanamine, 1-((6-chloroimidazo((2,1-b)thiazol-5-yl)sulfonyl)-, hydrochloride (1:1) |
2-[1-[(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]-1H-indol-3-yl]ethylamine Hydrochloride |
554403-08-6 |
詳細(xì)
|
| 1-((1-(2-aminopyrimidin-4-yl)-2-((2-methoxyethyl)amino)-1H-benzo[d]imidazol-6-yl)ethynyl)cyclohexanol |
GNE-2861 |
1394121-05-1 |
詳細(xì)
|
| VUF11207 |
VUF11207 |
1378524-41-4 |
詳細(xì)
|
| Src Inhibitor 3 |
Src Inhibitor 3 |
2380027-49-4 |
詳細(xì)
|
| Carbamic acid, N-[5-[2-(acetylamino)-6-benzothiazolyl]-2-methyl-3-pyridinyl]-, cyclohexyl ester |
PK68 |
2173556-69-7 |
詳細(xì)
|
| Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)- |
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)- |
1998705-62-6 |
詳細(xì)
|
| Ritanserin |
利坦絲林 |
87051-43-2 |
詳細(xì)
|
| 5H-Pyrazolo[4,3-c]pyridine-5-carboxamide, 3-[7-(difluoromethyl)-3,4-dihydro-6-(1-methyl-1H-pyrazol-4-yl)-1(2H)-quinolinyl]-1-[1-[15-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]amino]-1-oxo-4,7,10,13-tetraoxapentadec-1-yl]-4-piperidinyl]-1,4,6,7-tetrahydro-N-methyl- |
化合物DCBP-1 |
2484739-25-3 |
詳細(xì)
|
| 5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF |
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF |
2097117-06-9 |
詳細(xì)
|
| (S)-2-(6,7-DIHYDRO-5H-THIAZOLO[4,5-F]INDOL-2-YL)-4,5-DIHYDROTHIAZOLE-4-CARBOXYLIC ACID |
CYCLUC1 |
1247879-16-8 |
詳細(xì)
|
| Olumacostat Glasaretil |
OLUMACOSTAT GLASARETIL; DRM01B; DRM-01B; DRM 01B. |
1261491-89-7 |
詳細(xì)
|
| AP 20187 |
AP 20187 |
195514-80-8 |
詳細(xì)
|
| 8-benzyl-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one |
Furimazine |
1374040-24-0 |
詳細(xì)
|
| Val-cit-PAB-OH |
VAL-CIT-PAB |
159857-79-1 |
詳細(xì)
|
| NE 10790 |
NE 10790 |
152831-36-2 |
詳細(xì)
|
| 1(2H)-Pyridineacetamide, N-[4-(aminocarbonyl)-3-fluorophenyl]-4-[5-chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl]-α-ethyl-5-methoxy-2-oxo-, (αS)- |
ASUNDEXIAN |
2064121-65-7 |
詳細(xì)
|
| FLT3-IN-3 |
SAN50900 |
2229050-90-0 |
詳細(xì)
|
| Benzoic acid, 3-[2-[(2-fluorophenyl)amino]-5-oxazolyl]- |
3-(2-((2-氟苯基)氨基)惡唑-5-基)苯甲酸 |
2375281-44-8 |
詳細(xì)
|
| ATOLIHZIXHZSBA-BTSKBWHGSA-N |
ATOLIHZIXHZSBA-BTSKBWHGSA-N |
1312547-19-5 |
詳細(xì)
|
| CNX-500 |
CNX-500 |
1202758-21-1 |
詳細(xì)
|
| PXS 4728A |
PXS 4728A |
1478364-68-9 |
詳細(xì)
|
| 3-Piperidinecarboxylic acid, 1-[(2R)-2-[[4-(2-chloro-4-fluorophenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]-1-oxopropyl]-, (3S)- |
化合物IMT1B |
2304621-06-3 |
詳細(xì)
|
| 5-Phenyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide |
5-苯基-1,2,5-噻二唑烷-3-酮 1,1-二氧化物 |
612530-44-6 |
詳細(xì)
|
| 3-Isoxazolecarboxamide, N-[1-[[2,4-bis(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-5-(2-furanyl)- |
N-(1-(2,4-雙(三氟甲基)芐基)-1H-吡唑-4-基)-5-(呋喃-2-基)異惡唑-3-甲酰胺 |
2323027-38-7 |
詳細(xì)
|
| MT-802 |
MT-802 |
2231744-29-7 |
詳細(xì)
|
| FLT3-IN-4 |
FLT3-IN-4 |
2304799-09-3 |
詳細(xì)
|
| ml390 |
化合物ML390 |
2029049-79-2 |
詳細(xì)
|
| Ro 5-3335 |
化合物RO 5-3335 |
30195-30-3 |
詳細(xì)
|
| GSK620 |
GSK620 |
2088410-46-0 |
詳細(xì)
|
| 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 9-chloro-5,11-dihydro-5-propyl- |
化合物BI-0115 |
4929-23-1 |
詳細(xì)
|
| 3-(3-Methoxyphenyl)-2-Methyl-N-(2-(thiazol-4-yl)-1H-benzo[d]iMidazol-5-yl)propanaMide hydrochloride |
RY785 |
1393748-80-5 |
詳細(xì)
|
| 4-Methoxy-3-methylphenyl piperidin-1-yl sulphone, 2-Methyl-4-[(piperidin-1-yl)sulphonyl]anisole |
4-Methoxy-3-methylphenyl piperidin-1-yl sulphone, 2-Methyl-4-[(piperidin-1-yl)sulphonyl]anisole |
457961-34-1 |
詳細(xì)
|
| 6-Quinolinecarboxamide, 1-acetyl-4-[(5-chloro-2-pyrimidinyl)amino]-1,2,3,4-tetrahydro-2-methyl-, (2S,4R)- |
化合物I-BET567 |
1887237-54-8 |
詳細(xì)
|
| 2-Propen-1-one, 1-[6-[(4R)-4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]hept-2-yl]- |
JDQ-443 |
2653994-08-0 |
詳細(xì)
|
| COUMESTROL |
考邁斯托醇 |
479-13-0 |
詳細(xì)
|
| CC-90010 |
CC-90010 |
1706738-98-8 |
詳細(xì)
|
| MRK 560 |
MRK 560 |
677772-84-8 |
詳細(xì)
|
| TAK-041 |
1929519-13-0 |
1929519-13-0 |
詳細(xì)
|
| GCN2IB |
GCN2IB |
2183470-12-2 |
詳細(xì)
|
| Ethyl 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzene Sulfonamide Carbamate |
4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰胺基-甲酸乙酯 |
14511-59-2 |
詳細(xì)
|
| Methanone, [2-(ethylsulfonyl)phenyl][(2S)-4-(6-fluoro-2-benzothiazolyl)-2-methyl-1-piperazinyl]- |
化合物ARN19702 |
1971937-18-4 |
詳細(xì)
|
| 3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridinecarboxamide |
3-氨基-6-甲氧基-N-[(2S)-3,3,3-三氟-2-羥基-2-甲基丙基]-5-(三氟甲基)-2-吡啶甲酰胺 |
1334546-77-8 |
詳細(xì)
|
| Acetamide, 2-[3-[6-ethoxy-4-[[4-(1H-pyrazol-4-yl)phenyl]amino]-2-quinazolinyl]phenoxy]-N-(1-methylethyl)- |
KL11743 |
1369452-53-8 |
詳細(xì)
|
| 4-(4,4-DIMETHYL-3-(6-(3-(OXAZOL-2-YL)PROPYL)PYRIDIN-3-YL)-5-OXO-2-THIOXOIMIDAZOLIDIN-1-YL)-3-FLUORO-2-(TRIFLUOROMETHYL)BENZONITRILE |
GNF179 |
1261114-01-5 |
詳細(xì)
|
| 2-[2-Oxo-2-(2,2,4-trimethyl-3,4-dihydroquinolin-1(2H)-yl)ethyl]-1H-isoindole-1,3(2H)-dione |
2-[2-氧代-2-(2,2,4-三甲基-3,4-二氫-2H-喹啉-1-基)-乙基]-異吲哚-1,3-二酮 |
332382-54-4 |
詳細(xì)
|
| Ethanone, 1-[6-(3-chloro-4-hydroxyphenyl)-4-[[4-(diethylamino)cyclohexyl]amino]-3-quinolinyl]- |
化合物 OTS447 |
1356943-67-3 |
詳細(xì)
|
| 2BAct(eIF2B activator 2BAct) |
2BAct(eIF2B activator 2BAct) |
2143542-28-1 |
詳細(xì)
|
| GSK3186899 |
GSK3186899 |
1972617-87-0 |
詳細(xì)
|
| DCC3014 |
DCC3014 |
1628606-05-2 |
詳細(xì)
|
| 4-(1-(2-amino-5-chloropyrimidin-4-yl)-2-(thiaol-2-yl)but-30-yn-2-ol |
4-(1-(2-氨基-5-氯嘧啶-4-基)-2-(噻唑-2-基)-3-丁炔-2-醇 |
1202764-53-1 |
詳細(xì)
|
| 8-Quinolinecarbonitrile, 5-[(3R,5S)-3-amino-5-(trifluoromethyl)-1-piperidinyl]- |
化合物ENPATORAN |
2101938-42-3 |
詳細(xì)
|